beyfortus
astrazeneca ab - nirsevimab - immune sera og immunglobuliner, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
crestor 10 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 10 mg
crestor 5 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 5 mg
crestor 20 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 20 mg
crestor 40 mg
grünenthal gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg
nexium 40 mg
grünenthal gmbh (1) - esomeprazolmagnesiumtrihydrat - enterotablett - 40 mg
nexium 10 mg
grünenthal gmbh (1) - esomeprazolmagnesiumtrihydrat - enterogranulat til mikstur, suspensjon i dosepose - 10 mg
nexium 20 mg
grünenthal gmbh (1) - esomeprazolmagnesiumtrihydrat - enterotablett - 20 mg
nexium 40 mg
grünenthal gmbh (1) - esomeprazolnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 40 mg
seroquel 100 mg
cheplapharm arzneimittel gmbh - kvetiapinfumarat - tablett, filmdrasjert - 100 mg